35 related articles for article (PubMed ID: 23062926)
1. Monoclonal antibody-based therapies: a new dawn in the treatment of acute lymphoblastic leukemia.
Kantarjian H; Thomas D; Wayne AS; O'Brien S
J Clin Oncol; 2012 Nov; 30(31):3876-83. PubMed ID: 22891271
[No Abstract] [Full Text] [Related]
2. CD20-positive subcutaneous panniculitis-like T-cell lymphoma presenting as polycranial neuropathy: A CARE-compliant case report and literature review.
Xu J; Li J; Sun YJ; Quan W; Liu L; Zhang QH; Qin YD; Pei XC; Su H; Chen JJ
Medicine (Baltimore); 2022 Sep; 101(35):e30233. PubMed ID: 36107521
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous panniculitis-like T cell lymphoma arising in association with chronic lymphocytic leukaemia.
Kulumani Mahadevan LS; Ozdemirli M
BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34580127
[TBL] [Abstract][Full Text] [Related]
4. Peripheral T-Cell Lymphoma of the Submandibular Salivary Gland as an Unusual Manifestation of Richter's Syndrome: A Case Report and Literature Review.
Gorodetskiy VR; Probatova NA; Kondratieva TT
Case Rep Hematol; 2017; 2017():1262368. PubMed ID: 29410924
[TBL] [Abstract][Full Text] [Related]
5. Adjuvants and lymphoma risk as part of the ASIA spectrum.
Butnaru D; Shoenfeld Y
Immunol Res; 2015 Feb; 61(1-2):79-89. PubMed ID: 25582758
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous panniculitis-like T-cell lymphoma in a 26-month-old child with a review of the literature.
Yim JH; Kim MY; Kim HO; Cho B; Chung NG; Park YM
Pediatr Dermatol; 2006; 23(6):537-40. PubMed ID: 17155994
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous panniculitis-like T-cell lymphoma in a patient with history of B-cell lymphoma treated successfully with chemotherapy 15 years prior.
Dasanu CA; Gopal S; Davis LK; Atienza JA
J Oncol Pharm Pract; 2014 Jun; 20(3):233-5. PubMed ID: 23740379
[No Abstract] [Full Text] [Related]
8. [Subcutaneous panniculitis-like T-cell lymphoma following treatment with rituximab and cyclophosphamide].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2013 Mar; 140(3):246-7. PubMed ID: 23466166
[No Abstract] [Full Text] [Related]
9. Rapid development of infusion-related severe hypotension during rituximab therapy.
Vo KH; Waddell JA; Suda KJ
Ann Pharmacother; 2011 May; 45(5):e29. PubMed ID: 21505107
[TBL] [Abstract][Full Text] [Related]
10. Severe anemia caused by combination of autoimmune hemolysis, pure red cell aplasia and massive bone marrow infiltration in an elderly patient with chronic lymphocytic leukemia: successful treatment with rituximab.
Smolej L; Belada D; Cermanová M; Maisnar V; Lunáková E
Leuk Res; 2010 May; 34(5):e140-1. PubMed ID: 20053448
[No Abstract] [Full Text] [Related]
11. Subcutaneous panniculitis-like T-cell lymphoma after rituximab.
Sluzevich JC; Hall MR; Roy V
J Am Acad Dermatol; 2012 Nov; 67(5):e223-5. PubMed ID: 23062926
[No Abstract] [Full Text] [Related]
12. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
Robak T; Lech-Maranda E; Robak P
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
